Christopher David Ozeroff

General Counsel, Oruka Therapeutics, Inc.

Companies

Oruka Therapeutics, Inc.General counsel Feb 5, 2009 to Dec 16, 2021¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Oruka Therapeutics, Inc. ORKA50,970 shares²$3.8M at $73.87Dec 16, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 22, 2021Bought 50,000 shares at $2.26 of Oruka Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROruka Therapeutics, Inc., General counsel
2
SEC EDGAROruka Therapeutics, Inc. shares after the filing of Dec 16, 2021
3
SEC EDGARForm 4 filed Nov 23, 2021